Cargando…
In Vitro and In Vivo Enhancement of Temozolomide Effect in Human Glioblastoma by Non-Invasive Application of Cold Atmospheric Plasma
SIMPLE SUMMARY: Glioblastoma (GBM) is an aggressive type of brain cancer, with which only 25% of patients survive for more than one year. Treatment of GBM has remained a challenge due to its resistance to chemotherapy. Here, we aimed to assess the potential for a combination therapy of cold atmosphe...
Autores principales: | Soni, Vikas, Adhikari, Manish, Simonyan, Hayk, Lin, Li, Sherman, Jonathan H., Young, Colin N., Keidar, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430547/ https://www.ncbi.nlm.nih.gov/pubmed/34503293 http://dx.doi.org/10.3390/cancers13174485 |
Ejemplares similares
-
Theranostic Potential of Adaptive Cold Atmospheric Plasma with Temozolomide to Checkmate Glioblastoma: An In Vitro Study
por: Soni, Vikas, et al.
Publicado: (2022) -
A Novel Micro Cold Atmospheric Plasma Device for Glioblastoma Both In Vitro and In Vivo
por: Chen, Zhitong, et al.
Publicado: (2017) -
Combination therapy of cold atmospheric plasma (CAP) with temozolomide in the treatment of U87MG glioblastoma cells
por: Gjika, Eda, et al.
Publicado: (2020) -
The anti-glioblastoma effect of cold atmospheric plasma treatment: physical pathway v.s. chemical pathway
por: Yan, Dayun, et al.
Publicado: (2020) -
Cold atmospheric plasma, a novel promising anti-cancer treatment modality
por: Yan, Dayun, et al.
Publicado: (2016)